COVID-19 Outbreak Information –

Michael Stäheli
Head of Investor Relations and Corporate Communications
PolyPeptide Group AG
Dammstrasse 19
6300 Zug, Switzerland
investorrelations@polypeptide.com
Tel: +41 41 723 20 34